Stock CURE KINARUS THERAPEUTICS HOLDING AG
Add to a list
To use this feature you must be a member
Log inSign up

News Kinarus Therapeutics Holding AG

Equities

CURE

CH0009115129

Market Closed - Swiss Exchange
Other stock markets
 10:38:47 2024-04-26 am EDT 		5-day change 1st Jan Change
15 CHF -6.99% Intraday chart for Kinarus Therapeutics Holding AG -1.52% +737.05%
08:21am Kinarus Therapeutics Completes Merger with Unit, Rebrands as Curatis MT
Apr. 25 Curatis AG completed the acquisition of Kinarus Therapeutics Holding AG for CHF 18.3 million in a reverse merger transaction. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Kinarus Therapeutics Completes Merger with Unit, Rebrands as Curatis
MT
Business Combination of Kinarus Therapeutics Holding AG (now renamed to Curatis Holding AG) and Curatis AG completed
EQ
Curatis AG completed the acquisition of Kinarus Therapeutics Holding AG for CHF 18.3 million in a reverse merger transaction.
CI
Kinarus Therapeutics : Q&A on the Reverse Share Split
PU
Kinarus Therapeutics : Q&A on the Reverse Share Split” unter Financial News / Corporate News ablegen
PU
Kinarus Therapeutics Holding AG publishes FY2023 Financial Statements and announces details on Business Combination with Curatis AG and Reverse Share Split
EQ
Swiss Exchange Regulator Drops Inquiry Into Kinarus Therapeutics
MT
Extraordinary General Meeting of Kinarus Holding approved all resolutions relating to the envisaged Business Combination with Curatis
EQ
Publication of unaudited financial statements of Kinarus Therapeutics Holding AG (only) for FY2023
EQ
Kinarus Therapeutics Receives Swiss Court Approval for Revocation of Bankruptcy
MT
Courts of Basel-Stadt have revoked bankruptcy of Kinarus Therapeutics Holding AG
EQ
Kinarus Therapeutics Shares Surge on Combination Deal With Curatis
MT
Kinarus Therapeutics Holding AG in Liquidation and Curatis AG propose to combine companies and reverse bankruptcy procedures of Kinarus Therapeutics Holding AG in Liquidation
EQ
Curatis AG entered into a transaction agreement to acquire Kinarus Therapeutics Holding AG in a reverse merger transaction.
CI
Kinarus Therapeutics to File for Bankruptcy After Funding Efforts Fail
MT
Kinarus Therapeutics has decided to file for bankruptcy
EQ
Kinarus Therapeutics' H1 Loss Widens
MT
Kinarus Therapeutics Group Reports First Half 2023 Financial Results
EQ
Kinarus Therapeutics Sells License for Lung Disease Treatment to Shareholder Group
MT
Kinarus Therapeutics signed licensing agreement to extend cash for operations
EQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CURE Stock
  4. News Kinarus Therapeutics Holding AG